144313-54-2

Basic information

• Product Name: VALORPHIN
• Synonyms: VALORPHIN;VAL-VAL-TYR-PRO-TRP-THR-GLN;H-VAL-VAL-TYR-PRO-TRP-THR-GLN-OH
• CAS NO: 144313-54-2
• Molecular Formula: C44H60N8O12
• Molecular Weight: 892.99
• Mol File: 144313-54-2.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 1364.0±65.0 °C(Predicted)
• Appearance: /
• Density: 1.330±0.06 g/cm3(Predicted)
• Storage Temp.: -15°C
• PKA: 3.21±0.10(Predicted)
• CAS DataBase Reference: VALORPHIN(CAS DataBase Reference)
• NIST Chemistry Reference: VALORPHIN(144313-54-2)
• EPA Substance Registry System: VALORPHIN(144313-54-2)

Safety Data

• Hazardous Substances Data: 144313-54-2(Hazardous Substances Data)

Usage

Description

VALORPHIN is a semi-synthetic peptide compound derived from naturally occurring opioid peptides, which has emerged as a promising new class of analgesic drug. It exhibits potent pain-relieving properties with a reduced risk of side effects compared to traditional opioid medications. As a selective agonist for the mu opioid receptor, VALORPHIN modulates pain perception while minimizing the addictive potential associated with opioid drugs. Ongoing research is dedicated to optimizing its therapeutic properties and reducing the likelihood of abuse and addiction.

Uses

Used in Pharmaceutical Industry:
VALORPHIN is used as an analgesic agent for the management of moderate to severe pain. Its selective action on the mu opioid receptor provides effective pain relief while reducing the risk of addiction and side effects commonly associated with traditional opioid drugs.
Used in Pain Management:
VALORPHIN is utilized as a pain-relief medication for various conditions, including chronic and acute pain, due to its potent analgesic properties and lower potential for abuse and addiction.
Used in Research and Development:
VALORPHIN serves as a subject of ongoing research aimed at refining its properties for therapeutic use. This includes exploring its potential for treating specific types of pain and minimizing the risk of abuse and addiction, making it a valuable asset in the development of novel pain management strategies.